News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Olaparib-abiraterone combo improves PFS in mCRPC
16 Mar 2022
byRoshini Claire Anthony
The combination of olaparib and abiraterone in the first-line setting improved radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC), results of the phase III PROpel trial showed.
16 Mar 2022

Roxadustat proven safe, effective for anaemia in CKD patients
16 Mar 2022
Treatment with roxadustat leads to significant improvements in renal anaemia among patients with chronic kidney disease (CKD) by increasing haemoglobin (Hb) level and iron metabolism, according to a recent study. However, the risk of serious adverse events (AEs) during treatment must be considered.
16 Mar 2022







